Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 238 of 1,261
  1. AU 2021233167

    Compositions improving poxvirus stability

    BAVARIAN NORDIC AS [DK] · Granted Sep 22, 2022 · Expires Sep 17, 2042

    granted
  2. US 11447488

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  3. US 11445997

    Ultrasound imaging of biomarker sensitive hydrogels

    SENTIOMED, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  4. US 11446397

    Gene therapy vectors for treating heart disease

    Tenaya Therapeutics, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  5. US 11446380

    Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

    Alnylam Pharmaceuticals, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  6. US 11446365

    Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  7. US 11446342

    Composite probiotics and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  8. US 11446357

    Method for treating disease using FOXP3+CD4+ T cells

    Kyverna Therapeutics, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  9. US 11446383

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  10. US 11446389

    Maytansinoid derivatives, conjugates thereof, and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  11. US 11447498

    Fused tetracyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  12. US 11446332

    Combinatorial cancer immunotherapy

    Senti Biosciences, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  13. US 11446279

    Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  14. US 11447797

    AAV with unique capsid protein VP1 and methods of using for treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  15. US 11447830

    Gene signatures to predict drug response in cancer

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  16. US 11447753

    Non-neuroinvasive viruses and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  17. US 11447563

    Tumor selective macropinocytosis-dependent rapidly internalizing antibodies

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  18. US 11447537

    PDL2 compounds

    IO Biotech ApS · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  19. US 11446302

    Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  20. US 11447500

    Thienopyridine derivatives and pharmaceutical composition comprising same

    Wellmarker Bio Co., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  21. US 11447510

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  22. US 11447573

    Multispecific antigen binding proteins and methods of use thereof

    Nanjing Legend Biotech Co., Ltd · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  23. US 11446253

    Ionic liquids for internal delivery

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  24. US 11446271

    Methods and compositions for increasing the potency of antifungal agents

    PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.